Introduction
A common and adverse complication following a myocardial infarction (MI) is heart failure (HF). To prevent HF, and improve the prognosis it is necessary to identify high risk patients to initiate more intensive monitoring or treatment.
Prior to the clinical symptoms of HF become clear, patients can develop asymptomatic systolic or diastolic left ventricular (LV) dysfunction caused by structural or functional cardiac abnormalities which are precursors of HF. [1] [2] [3] [4] [5] [6] Recent studies have shown global longitudinal strain (GLS) obtained from 2D-speckle tracking echocardiography to be a strong predictor of adverse outcomes in several cardiac diseases. 5, [7] [8] [9] [10] [11] GLS has already been suggested as a more sensitive marker of cardiac function than conventional echocardiography. 4, [4] [5] [6] 12, 13 It has been demonstrated to be a more powerful predictor of outcome than left ventricular ejection fraction (LVEF) as it may reflect subclinical LV systolic dysfunction. 6, 14 Novel echocardiographic software can now sectionalize the myocardial wall in layers. This has made it possible to detect which layers of the myocardial wall that suffer from reduced deformation. Layerspecific GLS might be important since the LV wall is heterogeneous and consists of three different layers of muscle fibres. 15 Especially in ischaemic heart disease, layer-specific strain may be particularly useful since longitudinally orientated myocardial fibres located in the sub-endocardium is known to be most susceptible to ischaemia. 16 There are no studies that have investigated the prognostic value of layer-specific GLS in an acute coronary syndrome (ACS) population. This is what we aim to examine, especially the association between layer-specific GLS and the risk of developing HF and cardiovascular death (CD).
Methods

Study population
The Cardiology Department of Copenhagen University Hospital Gentofte is an invasive hub for 10 non-invasive cardiology departments. In the period January 2003 to November 2008, 5003 patients were admitted to the department for PCI, these patients were all included in a clinical registry. All patients in this registry were eligible for our study if they had an echocardiogram available. We hereby identified 580 ACS patients [ST-segment elevation myocardial infarction (STEMI), non-STsegment elevation myocardial infarction (NSTEMI), or unstable angina pectoris (UAP)] who were admitted to Copenhagen University Hospital Gentofte, Denmark for percutaneous coronary intervention (PCI) in the period and had an echocardiogram performed at Gentofte Hospital. A considerable number of the 5003 patients were admitted to other non-invasive cardiology departments and were rapidly transported back to their local hospital post-PCI. The echocardiographic examinations were performed [median 2 days (1-3 days)] after the PCI procedure. In addition, 115 patients were excluded due to a non-sinus rhythm, missing images, or inadequate image quality.
Outcomes and endpoints
Information regarding endpoints-development of HF and CD-were retrieved from the Danish National Board of Health's National Patient Registry and the Danish Register of Causes of Death using International Classifications of Diseases codes.
Echocardiography
The echocardiographic examinations were performed by experienced clinicians and sonographers on GE Vivid machines (GE Healthcare, Little Chalfont, UK). The images were stored in a GE Health care image vault and analysed offline with EchoPac version 113 (GE Healthcare, Horten, Norway) by an experienced investigator blinded to clinical baseline data and endpoints.
Conventional 2D echocardiography
The LV dimensions, interventricular septal thickness (IVSd), LV internal diameter (LVIDd), and LV posterior wall (LVPWd) thickness were measured in the parasternal long-axis view at the tip of the mitral valve leaflet in end-diastole. LV mass index (LVMI) was calculated as the anatomical mass 17 divided by body surface area. Mitral valve inflow patterns:
peak early filling (E-wave), atrial filling (A-wave) and deceleration time of the early filling (DT) were measured with pulsed-wave Doppler imaging at the tips of the mitral valve leaflets in the apical 4-chamber view. Additionally, early (e 0 ) peak myocardial diastolic velocity was measured with pulsed-wave tissue Doppler imaging in the apical 4-chamber view at the lateral and septal walls at the mitral annulus. The e 0 was indexed to the E-wave velocity to obtain the E/e 0 .
LVEF was measured with the modified Simpson's biplane method obtained from the apical 4-and 2-chamber views. Left atrial volume (LAV) was obtained through Simpson's biplane method as well. Using m-mode tricuspid annular plane systolic excursion (TAPSE) was measured in the apical 4-chamber view.
2D speckle tracking echocardiography
Speckle tracking analysis was performed in the three apical views-4-chamber, 2-chamber, and the longitudinal long-axis ( Figure 1) . The endocardium of the LV was traced with a semiautomatic function and adjusted manually with a point-and-click method if the investigator thought the tracing to be inaccurate. Width of the regions of interest (ROI) covered the endo-, myo-and epicardium and was adjusted regionally when required. Each view covered six segments-consequently a total of 18 segments were included. Global values were calculated manually as the mean value of the peak systolic longitudinal strain of each segment. Segments if deemed untraceable could be excluded at the discretion of the analyst. Two layers of longitudinal layer-specific strain: the endomyocardial (GLSendo) and epimyocardial (GLSepi) were calculated by the software. Whole wall GLS which encompasses the whole ROI was calculated by the software as well. Comparisons of the Harrell's c-statistics of the diagnostic models (Models 1, 2, and 3 with or without a GLS variable) were made to assess the incremental prognostic information gained from layered GLS.
Statistical analysis
Association between layer-specific GLS and adverse outcomes 
A comparison with a P-value < _0.05 in two-tailed tested was deemed statistically significant. STATA Statistics/Data analysis, MP 13.0 (StataCorp, TX, USA) was used for the statistical analysis.
Results
Of the 465 patients included, 176 (37.8%) developed HF, 38 suffered CD (8.2%), with 15 (3.2%) developing both. Overall there were 199 (42.7%) events during a median follow-up time of 4.6 (0.2-6.3) years. Follow-up was 100%.
The mean age of our study sample was 66 ± 12 years and 74.0% were males. The HF/CD group were significantly older (67 years vs. 64 years, P = 0.019), had higher HR during the echocardiogram [79 beats per minute (bpm) vs. 71 bpm, P < 0.001], had a higher frequency of prior CVD (14.1% vs. 6 .4%, P = 0.006), had a lower frequency of history of CVD in the family (23.6% vs. 34.6%, P = 0.011), a higher rate of LAD lesion (59.3% vs. 43 .6%, P < 0.001), and LMS stenosis (1.5% vs. 0.0%, P = 0.045) and a lower rate of right coronary artery (RCA) (29.6% vs. 40.2%, P = 0.018) and circumflex artery (Cx) occlusion (9.5% vs. 16 , 2%, P = 0.045) ( Table 1) .
Supplementary material online, Tables The longitudinal strain measurements-GLSendo (12% vs. 17%, P < 0.001), GLS (11% vs. 14%, P < 0.001), and GLSepi (9% vs. 13%, P < 0.001) were all significantly lower in the HF/CD group as well ( Table 1) .
Outcome
Both GLSendo, GLS, and GLSepi remained independently associated measures after adjustments in Models 1 and 2 with onset of the composite outcome (HF/CD) and each outcome when evaluated separately ( Table 2) . After adjusting for all the echocardiographic parameters (Model 3) GLSendo, GLS and GLSepi remained independently associated with the composite outcome and HF alone; however, only GLSepi remained independently associated with CD ( Table 2) . No other echocardiographic measures remained independently associated with the composite outcome ( Table 2) . The Kaplan-Meier curves ( Figure 2 ) displaying the patient cohort stratified into tertiles of GLSendo, GLS, and GLSepi, respectively, demonstrates the incrementally increased risk of developing HF and/ or CD with lower tertile of GLS. The lowest tertile displayed a eightto nine-fold increased risk of developing HF and/or CD compared to the highest tertile [GLSendo: 1 tertile vs. 3 tertile: hazard ratio 8.0 (5.1-12.5), P < 0.001; GLS: 1 tertile vs. 3 tertile: hazard ratio 9.2 (5.8-14.7), P < 0.001; GLSepi: 1 tertile vs. 3 tertile: hazard ratio 8.5 (5.4-13.2), P < 0.001]. The intermediate tertile had a three-to four-fold risk compared to the highest tertile [GLSendo: hazard ratio 3.2 (2.0-5.2), P < 0.001; GLS: hazard ratio 4.0 (2.5-6.6), P < 0.001; GLSepi: hazard ratio 3.5 (2.2-5.7), P < 0.001].
Incremental prognostic yield of GLS obtained from the different layers and whole wall
When comparing the Harrell's c-statistics obtained from unadjusted Cox regressions for GLSendo with the c-statistics obtained for GLS (0.733 vs. 0.739, P = 0.017) and c-statistics obtained for GLS compared to the c-statistics obtained for GLSepi (0.739 vs. 0.741, P = 0.38), we found the prognostic power of GLS to be significantly higher than that of GLSendo, and the c-statistics for GLS was lower than for GLSepi; however, this difference was not statistically significant.
Adding either GLS or GLSepi to all the variables included in Model 3 resulted in a significant increase in the c-statistics than Finally, we found no significant changes in Harrell's c-statistics when adding all the conventional echocardiographic parameters to the models when either one of the GLS measures were already included ( Figure 3) . Hence, neither of the models significantly improved when adding all other echocardiographic measures to the models where the GLS measures were already included.
Discussion
This is the first study evaluating the association between layerspecific GLS and HF and/or CD following ACS. In the present study, we found that all three layer-specific GLS measurements provided superior prognostic information on the risk of developing HF and/or CD compared to all other echocardiographic measure. Both GLS obtained from the epicardial layer and the whole wall provided incremental prognostic information when added to all other predictors in the current population. GLSepi was, however, the only independent echocardiographic predictor of CD alone. In addition, the risk assessment did not significantly improve when adding all other significantly associated echocardiographic parameters to the models when either GLSendo, GLS, or GLSepi were already included (Figure 3) .
In our study, patients developing HF and/or CD were older, had a higher tendency of prior CVD, and increased HR, which is consistent with the literature. 3 Cardiac imaging especially transthoracic echocardiography plays a central role in the assessment of LV function following MI 18 and in diagnosis of HF. 3 One of the strongest predictors of survival in ACS patients is LV function evaluated with an echocardiogram before hospital discharge. 18 Echocardiography is the most common imaging method to evaluate regional and global LV function after STEMI. In the presence of severe LV systolic dysfunction, it is recommended to re-evaluate with a subsequent echocardiogram around 6-12 weeks after initial hospitalization. 18 Currently only LVEF and not GLS is recommended when assessing systolic function. 17 This is in spite of the fact that LVEF can be preserved in the presence of HF. This is hypothesized to be due to an increase in the circumferential and radial myocardial deformation occurring concomitant with an impaired longitudinal deformation which can be identified using speckle tracking imaging. 4, 6 Hence, LVEF remains preserved despite of a reduced longitudinal deformation. Layer-specific GLS has been suggested as a potential method of assessing LV function. 19, 20 Several studies have demonstrated layerspecific GLS to be independently associated with the presence of coronary artery disease. Yet these studies display a discrepancy in which specific layer they found to have the strongest diagnostic power. [21] [22] [23] [24] GLSendo and circumferential endocardial strain have also been displayed to be associated with subsequent cardiac events in patients with chronic ischaemic cardiomyopathy. 25 However, there are no published studies evaluating the prognostic value of layer-specific GLS for HF and/or CD following ACS.
In the present report, the magnitude of layer-specific GLS decreased from the endocardium to the epicardium (Tables 1 and 2) , which is in concordance with previous studies. 19, [21] [22] [23] We found all layers of GLS to be associated with HF and/or CD, after adjusting for clinical and echocardiographic parameters. Yet, GLSepi and GLS displayed stronger prognostic power (Table 2, Figure 3 ). In our adjusted models, the hazard ratios of layer-specific GLS increased in size from the endocardium to the epicardium per 1% decrease ( Table 2) . GLSepi remained as the only independent predictor when predicting only CD ( Table 2) . Our group has recently demonstrated similar results when using layer-specific GLS to diagnose ischaemia in a cohort of 80 patients with stable angina pectoris. In this study, we found that GLSepi was the only independent echocardiographic measure associated with the presence of significance of coronary artery stenosis after multivariable adjustment. 23, 24 These findings, like the results of the present report, which demonstrates that GLSepi might be the best measure both to diagnose significant coronary artery stenosis, but more importantly, subsequent outcome, are however still in contrary to other studies using layer-specific GLS. Zhang et al. 21 (cohort of 139 patients with 79 having complex coronary artery disease) and Sarvari et al. 22 (cohort of 77 patients with 49 having significant coronary artery disease) found GLSendo to be the best measurement in identifying complex coronary artery disease and predicting the severity of coronary lesions in NSTEMI patients.
We have tested the intra-and inter-observer variability of layered 2D-speckle tracking echocardiography in 20 patients with ischaemic heart disease. Intra-observer Bland-Altman analysis displayed a bias of 0.473 ± 1.45 with coefficients of variation (CV) of 6.6% for GLSendo, 0.447 ± 1.21 with CV of 6.4% for GLS, and 0.420 ± 1.07 with CV of 6.5% for GLSepi. Whereas, the inter-observer analysis displayed a bias of -0.965 ± 2.36 with CV of 11.1% for GLSendo, -0.887 ± 1.92 with a CV of 10.5% for GLS, and -0.815 ± 1.64 with a CV of 10.3% for GLSepi. 23, 24 The better reproducibility of 2D-speckle tracking of the epimyocardium than that of the endomyocardium might be one of the reasons several new studies found GLSepi to be the best measure for diagnostic and prognostic purposes. Association between layer-specific GLS and adverse outcomes This might be due to the better traceability of the epimyocardium as opposed to that of the endocardial border. The endomyocardial region might generally be affected to a higher degree than the epimyocardial region from several factors. Such factors could be the more varied contour of the endocardial border, which can make it more difficult to line up the ROI. Apical foreshortening might also influence the traceability of apical endocardial border, whereas the epicardial border would be less evasive. Apical foreshortening has been shown to affect longitudinal strain values significantly. 26 Additionally, regional epimyocardial longitudinal strain has been Figure 3 Incremental prognostic information when adding layer-specific strain. (A) Column diagram displaying Harrell's Cstatistics comparison in various models for predicting HF and/or CD with or without GLSendo GLS or GLSepi. Model 1 includes age, gender BMI, prior CVD, family history of CVD, DM, current smoker, hypercholesterolaemia, systolic blood pressure, diastolic blood pressure, and heart rate. Model 2 includes the same variables as Model 1 along with the PCI variables-STEMI, multivessel culprit lesions, LAD occlusion and LMS occlusion. Model 3 includes the same variable as Models 1 and 2 in addition to LVMI, LVEF, DT, e 0 , and E/e 0 . 95% CI included. BMI, body mass index; CD, cardiovascular death; CI, confidence interval; CVD, cardiovascular disease; DM, diabetes mellitus; DT, deceleration time; e 0 , early peak myocardial diastolic velocity; E/e 0 , peak early filling velocity divided by early peak myocardial diastolic velocity; GLS, whole wall global longitudinal strain; GLSendo, endocardial global longitudinal strain; GLSepi, epimyocardial global longitudinal strain; HF, heart failure; LAD, left anterior descending, LMS, left main stem; LVEF, left ventricular ejection fraction; LVMI, left ventricle mass index; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction.
Figure 2
Layer-specific strain and outcome. The Kaplan-Meier curves displaying the probability of staying event free. The horizontal axis displays the time from the ACS expressed in days. The vertical axis represents the cumulative probability of staying event free of HF and/or CD. The study population is stratified into three groups based on the tertiles of GLSendo, GLS, or GLSepi. 95% CI and hazard ratios included. Number of patient at risk at every 1000 days is displayed below each curve. CD, cardiovascular death; CI, confidence interval; GLS, whole wall global longitudinal strain; GLSendo, endocardial global longitudinal strain; GLSepi, epimyocardial global longitudinal strain; HF, heart failure.
shown to be more homogenous than the inner two layers, which have significant variance from base to apex. 19 As mentioned previously it is currently not recommended to evaluate GLS after ACS or when diagnosing HF. 3, 17 Applying speckle tracking echocardiography to the standard echocardiographic workup following ACS would require little additional time and effort. Furthermore, due to the semi-automated nature of the method, the intra-and inter-observer variability is low. The superiority of layerspecific longitudinal strain as well as whole wall longitudinal strain when compared to LVEF indicates that it might be time to reassess the recommendations on LV function measurements. We demonstrated both layer-specific GLSendo and GLSepi and GLS to provide superior prognostic information regarding the risk of developing HF and/or CD compared to all other echocardiographic measures. We find that it might be clinically relevant to add GLSepi, GLSendo, and GLS to the risk stratification scheme of ACS patients. This could assist in identifying patients at greatest risk of adverse morbidity and mortality.
Limitations
There may be residential confounders as this is a retrospectively planned study. However, the analysis was based on consecutive patients from a well-defined registry. (92.9-100%), when reviewing discharge summaries and medical records. 27, 28 Unfortunately, the degree of mitral regurgitation was not reassessed in the present study. Information about the medication of the patients such as the use of betablockers was not available either. Data on medication as well as mitral regurgitation would have resulted in a more thorough description of the cohort. Furthermore, we regret we were not able to examine changes in medication following discharge from the hospital. There might be some concerns regarding overfitting, when utilizing a multivariable Cox regression with as many variables included as in Model 3. However, interpretation of an overfitted multivariable Cox regression can still be acceptable, when it is done to control for potential confounders and not for building a prediction model. 29 One of the challenges of speckle tracking is defining the epicardial border, which in some cases can appear unclear and hence may bias GLSepi. However, we have found that intra-and inter-observer reproducibility is superior for GLSepi when compared to GLSendo and whole wall GLS, hence, this issue does not seem to make GLSepi a less valid measure. Regretfully, follow-up echocardiograms were not performed for the present study. Lastly, we cannot exclude the possibility of patients having an undiagnosed pre-existing condition prior to their initial ACS hospitalization influencing our results.
Conclusion
Layer-specific GLSendo, GLS, and GLSepi were all independently associated with HF and/or CD. GLS and GLSepi provided incremental prognostic information when added to all other significantly associated measures.
